Italian Drugmaker Chiesi to Acquire KalVista for $1.9 Billion
Chiesi's Strategic Expansion in Rare Disease Drugs
Acquisition Details
Deal Overview
April 29 (Reuters) - Italy's Chiesi has agreed to buy KalVista Pharmaceuticals for about $1.9 billion, the company said on Wednesday, as it looks to grow its rare disease drug portfolio.
Reporting and Editorial Information
(Reporting by Kamal Choudhury in Bengaluru; Editing by Shailesh Kuber)

